Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor SAR442168

Condition:   Relapsing Multiple Sclerosis Interventions:   Drug: SAR442168;   Drug: Teriflunomide HMR1726;   Drug: Placebo to match SAR442168;   Drug: Placebo to match Teriflunomide Sponsor:   Sanofi Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials